Kejako Company
Kejako develops a non-invasive solution for interested presbyopic patients seeking to keep their quality of life through the compensation of visual accommodation decay. Addressing presbyopia in the field of ophthalmology, with an anti-aging mindset in order to treat the gradual loss of visual accommodation.
Technology:
P4 Medicine
Industry:
P4 Medicine
Headquarters:
Geneva
Founded Date:
2015-07-01
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
2
Total Funding:
CHF700K
Estimated Revenue:
$1M to $10M
Last Funding Type:
Seed
Register and Claim Ownership